Dr. med. univ. ANDREAS STADLMAYR

Seit 01.04.2017:  Niedergelassener Internist mit Kassenvertrag

04/2017-04/2020: Gruppenpraxis mit Dr. Wolfgang Schur

2012-2017: Oberarzt im Krankenhaus Oberndorf

2010-2012: Facharzt für Innere Medizin im Krankenhaus Oberndorf

2007-2010: Assistenzarzt für Innere Medizin Krankenhaus Oberndorf

04/2007 - 11/2007: Assistenzarzt Universitätsklinik für Innere Medizin II der SALK (Abteilung für Kardiologie und Internistische Intensivmedizin)

2004-04/2007: Assistenzarzt Universitätsklinik für Innere Medizin I der SALK (Abteilung für Gastroenterologie und Hepatologie, Nephrologie und Stoffwechselerkrankungen)

2001-2004: Ausbildung zum Arzt für Allgemeinmedizin Landeskrankenhaus Salzburg

2000-2001: Betreuung der SAPHIR Studie (Arteriosklerosepräventionsprogramm) LKH Salzburg

1992-2000: Studium Humanmedizin Leopold Franzens Universität Innsbruck

1991-1992: Präsenzdienst

1991: Matura Missionsprivatgymnasium St. Rupert in Bischofshofen

DIPLOME/ADDITIVFACH:

• Facharzt für Innere Medizin

• Additivfach für Gastroenterologie und Hepatologie
• Facharzt für Allgemein- und Familienmedizin
• Diplom für Echokardiographie
• Diplom für Sportmedizin
• Diplom für Ernährungsmedizin
• Diplom für Geriatrie
• Diplom für Palliativmedizin
• Gültiges Notarztdiplom

MITGLIEDSCHAFT BEI FACHGESELLSCHAFTEN:

• ÖGIM: Österreichische Gesellschaft für Innere Medizin
• DGIM: Deutsche Gesellschaft für Innere Medizin
• ÖDG: Österreichische Gesellschaft für Diabetologie
• ÖGGH: Österreichische Gesellschaft für Gastroenterologie und Hepatologie
• ÖAG: Österreichische Adipostasgesellschaft
• ÖGSMP: Österreichische Gesellschaft für Sportmedizin

PUBLIKATIONEN:

1
Association between Cardiovascular Risk and Diabetes with Colorectal Neoplasia: A Site-Specific Analysis.
Niederseer D, Bracher I, Stadlmayr A, Huber-Schönauer U, Plöderl M, Obeid S, Schmied C, Hammerl S, Stickel F, Lederer D, Patsch W, Aigner E, Datz C.
J Clin Med. 2018 Nov 27;7(12):484. doi: 10.3390/jcm7120484.
PMID: 30486335 Free PMC article.
2
HFE hemochromatosis screening in patients with severe hip osteoarthritis: A prospective cross-sectional study.
Oppl B, Husar-Memmer E, Pfefferkorn S, Blank M, Zenz P, Gollob E, Wurnig C, Engel A, Stadlmayr A, Uyanik G, Brozek W, Klaushofer K, Zwerina J, Datz C.
PLoS One. 2018 Nov 14;13(11):e0207415. doi: 10.1371/journal.pone.0207415. eCollection 2018.
PMID: 30427934 Free PMC article.
3
Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathy.
Dejaco C, Stadlmayr A, Duftner C, Trimmel V, Husic R, Krones E, Zandieh S, Husar-Memmer E, Zollner G, Hermann J, Gretler J, Lackner A, Ficjan A, Datz C, Axman R, Zwerina J.
Arthritis Res Ther. 2017 Oct 24;19(1):243. doi: 10.1186/s13075-017-1448-0.
PMID: 29065925 Free PMC article.
4
Cardiovascular Risk and Known Coronary Artery Disease Are Associated With Colorectal Adenoma and Advanced Neoplasia.
Niederseer D, Stadlmayr A, Huber-Schönauer U, Plöderl M, Schmied C, Lederer D, Patsch W, Aigner E, Datz C.
J Am Coll Cardiol. 2017 May 9;69(18):2348-2350. doi: 10.1016/j.jacc.2017.02.065.
PMID: 28473143 Free article. No abstract available.
5
Characterization of the B Cell Receptor Repertoire in the Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in Colorectal Adenoma and Carcinoma.
Zhang W, Feng Q, Wang C, Zeng X, Du Y, Lin L, Wu J, Fu L, Yang K, Xu X, Xu H, Zhao Y, Li X, Schoenauer UH, Stadlmayr A, Saksena NK, Tilg H, Datz C, Liu X.
J Immunol. 2017 May 1;198(9):3719-3728. doi: 10.4049/jimmunol.1602039. Epub 2017 Mar 27.
PMID: 28348270
6
Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
Stättermayer AF, Traussnigg S, Aigner E, Kienbacher C, Huber-Schönauer U, Steindl-Munda P, Stadlmayr A, Wrba F, Trauner M, Datz C, Ferenci P.
J Trace Elem Med Biol. 2017 Jan;39:100-107. doi: 10.1016/j.jtemb.2016.08.006. Epub 2016 Aug 20.
PMID: 27908400
7
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
Feldman A, Eder SK, Felder TK, Kedenko L, Paulweber B, Stadlmayr A, Huber-Schönauer U, Niederseer D, Stickel F, Auer S, Haschke-Becher E, Patsch W, Datz C, Aigner E.
Am J Gastroenterol. 2017 Jan;112(1):102-110. doi: 10.1038/ajg.2016.318. Epub 2016 Aug 16.
PMID: 27527746
8
Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians: teply to Dr. Guo.
Patsch W, Stadlmayr A, Aigner E, Datz C.
Acta Diabetol. 2016 Feb;53(1):127-8. doi: 10.1007/s00592-015-0748-6. Epub 2015 Apr 10.
PMID: 25860159 No abstract available.
9
Natural course of subjects with elevated liver tests and normal liver histology.
Strasser M, Stadlmayr A, Haufe H, Stickel F, Ferenci P, Patsch W, Feldman A, Weghuber D, Datz C, Aigner E.
Liver Int. 2016 Jan;36(1):119-25. doi: 10.1111/liv.12935. Epub 2015 Sep 6.
PMID: 26256590 Free article.
10
Parathyroid Hormone is Related to Dysplasia and a Higher Rate of Distal Colorectal Adenoma in Women but Not Men.
Aigner E, Stadlmayr A, Huber-Schönauer U, Zwerina J, Husar-Memmer E, Niederseer D, Eder SK, Stickel F, Pirich C, Schett G, Patsch W, Datz C.
Horm Cancer. 2015 Aug;6(4):153-60. doi: 10.1007/s12672-015-0227-0. Epub 2015 May 29.
PMID: 26021763 Free PMC article.
11
Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations.
Stättermayer AF, Traussnigg S, Dienes HP, Aigner E, Stauber R, Lackner K, Hofer H, Stift J, Wrba F, Stadlmayr A, Datz C, Strasser M, Maieron A, Trauner M, Ferenci P.
J Hepatol. 2015 Jul;63(1):156-63. doi: 10.1016/j.jhep.2015.01.034. Epub 2015 Feb 9.
PMID: 25678388
12
Gut microbiome development along the colorectal adenoma-carcinoma sequence.
Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, Su L, Li X, Li X, Li J, Xiao L, Huber-Schönauer U, Niederseer D, Xu X, Al-Aama JY, Yang H, Wang J, Kristiansen K, Arumugam M, Tilg H, Datz C, Wang J.
Nat Commun. 2015 Mar 11;6:6528. doi: 10.1038/ncomms7528.
PMID: 25758642 Free article.
13
Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians.
Stadlmayr A, Aigner E, Huber-Schönauer U, Niederseer D, Zwerina J, Husar-Memmer E, Hohla F, Schett G, Patsch W, Datz C.
Acta Diabetol. 2015 Feb;52(1):39-46. doi: 10.1007/s00592-014-0596-9. Epub 2014 May 22.
PMID: 24849007
14
Gender- and site-specific differences of colorectal neoplasia relate to vitamin D.
Aigner E, Stadlmayr A, Huber-Schönauer U, Zwerina J, Husar-Memmer E, Niederseer D, Trauner M, Heuberger A, Hohla F, Schett G, Patsch W, Datz C.
Aliment Pharmacol Ther. 2014 Dec;40(11-12):1341-8. doi: 10.1111/apt.12981. Epub 2014 Oct 2.
PMID: 25278035
15
Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
Stickel F, Buch S, Zoller H, Hultcrantz R, Gallati S, Österreicher C, Finkenstedt A, Stadlmayr A, Aigner E, Sahinbegovic E, Sarrazin C, Schafmayer C, Braun F, Erhart W, Nothnagel M, Lerch MM, Mayerle J, Völzke H, Schaller A, Kratzer W, Boehm BO, Sipos B, D'Amato M, Torkvist L, Stal P, Arlt A, Franke A, Becker T, Krawczak M, Zwerina J, Berg T, Hinrichsen H, Krones E, Dejaco C, Strasser M, Datz C, Hampe J.
Hum Mol Genet. 2014 Jul 15;23(14):3883-90. doi: 10.1093/hmg/ddu076. Epub 2014 Feb 20.
PMID: 24556216 Free article.
16
HFE-related hemochromatosis: an update for the rheumatologist.
Husar-Memmer E, Stadlmayr A, Datz C, Zwerina J.
Curr Rheumatol Rep. 2014 Jan;16(1):393. doi: 10.1007/s11926-013-0393-4.
PMID: 24264720 Review.
17
VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis.
Nell-Duxneuner V, Axmann R, Husar-Memmer E, Dallos T, Datz C, Stadlmayr A, Aigner E, Englbrecht M, Schett G, Zwerina J.
Ann Rheum Dis. 2013 Dec;72(12):2006-10. doi: 10.1136/annrheumdis-2012-202800. Epub 2013 Apr 18.
PMID: 23599437
18
Risk of hepatitis C virus transmission from patients to healthcare workers: a prospective observational study.
Strasser M, Aigner E, Schmid I, Stadlmayr A, Niederseer D, Patsch W, Datz C.
Infect Control Hosp Epidemiol. 2013 Jul;34(7):759-61. doi: 10.1086/671004. Epub 2013 May 22.
PMID: 23739085 No abstract available.
19
Idiopathic hand osteoarthritis vs haemochromatosis arthropathy--a clinical, functional and radiographic study.
Dallos T, Sahinbegovic E, Stamm T, Aigner E, Axmann R, Stadlmayr A, Englbrecht M, Datz C, Schett G, Zwerina J.
Rheumatology (Oxford). 2013 May;52(5):910-5. doi: 10.1093/rheumatology/kes392. Epub 2013 Jan 12.
PMID: 23315789
20
Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations.
Aigner E, Felder TK, Oberkofler H, Hahne P, Auer S, Soyal S, Stadlmayr A, Schwenoha K, Pirich C, Hengster P, Datz C, Patsch W.
J Nutr Biochem. 2013 Jan;24(1):112-7. doi: 10.1016/j.jnutbio.2012.02.017. Epub 2012 Jul 21.
PMID: 22819549 Clinical Trial.
21
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
Rick FG, Seitz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Buchholz S, Block NL, Hohla F.
Cell Cycle. 2012 Nov 15;11(22):4203-10. doi: 10.4161/cc.22498. Epub 2012 Oct 24.
PMID: 23095641 Free PMC article.
22
Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
Stättermayer AF, Rutter K, Beinhardt S, Scherzer TM, Stadlmayr A, Hofer H, Wrba F, Steindl-Munda P, Krebs M, Datz C, Trauner M, Ferenci P.
J Hepatol. 2012 Sep;57(3):492-8. doi: 10.1016/j.jhep.2012.04.036. Epub 2012 May 24.
PMID: 22634340
23
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Rick FG, Buchholz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Aigner E, Perez R, Seitz S, Block NL, Hohla F.
Cell Cycle. 2012 Jul 1;11(13):2518-25. doi: 10.4161/cc.20900. Epub 2012 Jul 1.
PMID: 22751419 Free PMC article.
24
Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia.
Stadlmayr A, Aigner E, Steger B, Scharinger L, Lederer D, Mayr A, Strasser M, Brunner E, Heuberger A, Hohla F, Steinwendner J, Patsch W, Datz C.
J Intern Med. 2011 Jul;270(1):41-9. doi: 10.1111/j.1365-2796.2011.02377.x. Epub 2011 Apr 25.
PMID: 21414047 Free article.
25
A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
Aigner E, Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A, Solioz M, Tilg H, Patsch W, Weiss G, Stickel F, Datz C.
Am J Gastroenterol. 2010 Sep;105(9):1978-85. doi: 10.1038/ajg.2010.170. Epub 2010 Apr 20.
PMID: 20407430
26
A European evidence-based guideline for the prevention of type 2 diabetes.
Paulweber B, Valensi P, Lindström J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, Sheppard KE, Charlesworth K, Felton AM, Hall M, Rissanen A, Tuomilehto J, Schwarz PE, Roden M, Paulweber M, Stadlmayr A, Kedenko L, Katsilambros N, Makrilakis K, Kamenov Z, Evans P, Gilis-Januszewska A, Lalic K, Jotic A, Djordevic P, Dimitrijevic-Sreckovic V, Hühmer U, Kulzer B, Puhl S, Lee-Barkey YH, AlKerwi A, Abraham C, Hardeman W, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeif…
See abstract for full author list ➔
Horm Metab Res. 2010 Apr;42 Suppl 1:S3-36. doi: 10.1055/s-0029-1240928. Epub 2010 Apr 13.
PMID: 20391306 Free article.
27
Iron stores, liver transaminase levels and metabolic risk in healthy teenagers.
Aigner E, Hinz C, Steiner K, Rossmann B, Pfleger J, Hohla F, Steger B, Stadlmayr A, Patsch W, Datz C.
Eur J Clin Invest. 2010 Feb;40(2):155-63. doi: 10.1111/j.1365-2362.2009.02238.x. Epub 2009 Dec 27.
PMID: 20050877
28
Effect of obesity and insulin sensitivity on adiponectin isoform distribution.
Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, Tschoner A, Sandhofer A, Paulweber B, Ebenbichler CF, Patsch JR.
Eur J Clin Invest. 2008 Nov;38(11):827-34. doi: 10.1111/j.1365-2362.2008.02028.x.
PMID: 19021700
29
Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians.
Heid IM, Wagner SA, Gohlke H, Iglseder B, Mueller JC, Cip P, Ladurner G, Reiter R, Stadlmayr A, Mackevics V, Illig T, Kronenberg F, Paulweber B.
Diabetes. 2006 Feb;55(2):375-84. doi: 10.2337/diabetes.55.02.06.db05-0747.
PMID: 16443770
30
Associations of a human G protein beta3 subunit dimorphism with insulin resistance and carotid atherosclerosis.
Wascher TC, Paulweber B, Malaimare L, Stadlmayr A, Iglseder B, Schmoelzer I, Renner W.
Stroke. 2003 Mar;34(3):605-9. doi: 10.1161/01.STR.0000058159.63950.EA. Epub 2003 Feb 20.
PMID: 12624279
31
Intima media thickness of carotid arteries is reduced in heterozygous carriers of the Gly972Arg variant in the insulin receptor substrate-1 gene.
Hölzl B, Iglseder B, Stadlmayr A, Hedegger M, Moré E, Reiter R, Sandhofer F, Paulweber B.
Eur J Clin Invest. 2003 Feb;33(2):110-6. doi: 10.1046/j.1365-2362.2003.01113.x.
PMID: 12588284